Anti-IL-23 therapy for the treatment of moderate-to-severe inverse psoriasis: A 52-week multicentre study.

Filiaciones

Ceravalls J:

Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, Spain

Ruiz-Villaverde R:

Department of Dermatology, University Hospital San Cecilio, Instituto Biosanitario de Granada, Ibs, Granada, Spain

Armesto S:

Department of Dermatology, Marqués de Valdecilla University Hospital, Santander, Spain

Fernández-Armenteros JM:

Department of Dermatology, Hospital de Viladecans, Barcelona, Spain

Department of Dermatology, Hospital Universitari Arnau de Vilanova, Lleida, Spain

Riera-Monroig J:

Department of Dermatology, Hospital Clínic de Barcelona, Barcelona, Spain

Gracia-Cazaña T:

Department of Dermatology, Hospital Miguel Servet, Zaragoza, Spain

Quintana-Codina M:

Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, Spain

Iglesias-Sancho M:

Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, Spain

Salleras M:

Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, Spain

Moya AI:

Department of Dermatology, Hospital Universitario Severo Ochoa, Madrid, Spain

Melgosa Ramos FJ:

Department of Dermatology, Hospital Lluís Alcanyís de Xàtiva, Xàtiva, Spain

Ferran M:

Department of Dermatology, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain